The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Disparities between African American and Caucasian patients with MM
Joseph Mikhael, MD, MEd, FRCPC, FACP, Translational Genomics Research Institute (TGen), City of Hope Cancer Center, CA, discusses the disparity in prevalence, diagnosis and treatment of multiple myeloma (MM) between Caucasian and African American patient populations in the US. Dr Mikhael outlines the International Myeloma Foundation’s African American Initiative which aims to engage with the African American community, educate primary physicians about disparities in diagnosis and to improve understanding of MM in African Americans. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
Disclosures
Consultant for Amgen, BMS, Karyopharm, Janseen, Sanofi and Takeda
